Genmab Logo

Genmab

Creates and develops antibody therapeutics for cancer and other serious diseases.

GMAB | CO

Overview

Corporate Details

ISIN(s):
DK0010272202 (+2 more)
LEI:
529900MTJPDPE4MHJ122
Country:
Denmark
Address:
Carl Jacobsens Vej 30, 2500 Valby

Description

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-30 23:41
4
English ZIP 8.6 KB
2025-12-30 23:24 English ZIP 13.1 KB
2025-12-29 23:16
4
English ZIP 8.1 KB
2025-12-29 14:27
6-K
English ZIP 113.1 KB
2025-12-29 14:10
291225_CA55_Portfolio Update-en_d7a5f1dc-e2ae-4b83-83df-a265bc4a21bf.pdf (Engli…
English PDF 227.6 KB
2025-12-29 14:10
GenmabAS-1001156921-en_c7b3985d-c6b0-475e-ad26-b10d4d648b4b.html (English)
English HTML 8.2 KB
2025-12-22 23:15
4
English ZIP 7.8 KB
2025-12-19 18:32 English ZIP 5.6 MB
2025-12-18 23:54
4
English ZIP 7.8 KB
2025-12-18 23:49
3
English ZIP 7.3 KB
2025-12-12 13:00
6-K
English ZIP 114.5 KB
2025-12-01 22:46
6-K
English ZIP 117.5 KB
2025-12-01 22:24
Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial…
English PDF 252.1 KB
2025-12-01 22:24
Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial…
Danish HTML 7.0 KB
2025-11-26 13:04
6-K
English ZIP 59.0 KB

Automate Your Workflow. Get a real-time feed of all Genmab filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Genmab

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Genmab via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.